Literature DB >> 4042319

Determination of prolinase activity in plasma. Application to liver disease and its relation with prolidase activity.

I Myara, P Marcon, A Lemonnier, B Chateliér, M Mangeot.   

Abstract

We describe prolinase (EC 3.4.13.8) activity in human plasma for the first time. Optimum activity was obtained with prolylvaline as substrate and 0.02 mmol/L manganese concentration at pH 9.0. Moreover, preincubation with manganese was not required, contrary to prolidase (EC 3.4.13.9) activity. The mean value observed in 106 subjects without liver and renal disorders was 16 U/L +/- 14 (2 SD). We determined this plasma enzyme activity in patients with acute hepatitis and chronic liver disease. Plasma prolinase activity was strongly dependent upon cytolysis because of the high activity in liver and the low activity in plasma. Of 24 patients with chronic liver disease (4 chronic hepatitis and 20 cirrhosis) and without cytolysis, prolinase activity was slightly increased in only three patients, whereas prolidase activity was increased in 13. This could be due to a difference in the activation of these two enzymes in liver during the fibrotic process.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4042319     DOI: 10.1016/s0009-9120(85)80043-6

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  5 in total

1.  Prolidase and oxidative stress in chronic hepatitis C.

Authors:  Fazilet Duygu; Suda Tekin Koruk; Hasan Karsen; Nurten Aksoy; Abdullah Taskin; Melek Hamidanoglu
Journal:  J Clin Lab Anal       Date:  2012-07       Impact factor: 2.352

2.  Prolidase activity dysregulation and its correlation with oxidative-antioxidative status in chronic obstructive pulmonary disease.

Authors:  Mehmet Gencer; Nurten Aksoy; E Canan Dagli; Elmas Uzer; Sahin Aksoy; Sahbettin Selek; Hakim Celik; Hale Cakir
Journal:  J Clin Lab Anal       Date:  2011       Impact factor: 2.352

3.  Serum prolidase enzyme activity and oxidative stress levels in patients with diabetic neuropathy.

Authors:  Refah Sayın; Mehmet Aslan; Mehmet Emin Kucukoglu; Arda Luleci; Murat Atmaca; Ramazan Esen; Halit Demir
Journal:  Endocrine       Date:  2013-12-18       Impact factor: 3.633

4.  Does prolidase indicate worsening of hepatitis B infection?

Authors:  Fazilet Duygu; Nurten Aksoy; Aysegul Copur Cicek; Ilknur Butun; Sebnem Unlu
Journal:  J Clin Lab Anal       Date:  2013-09       Impact factor: 2.352

5.  Serum prolidase activity and oxidant-antioxidant status in children with chronic hepatitis B virus infection.

Authors:  Velat Şen; Ünal Uluca; Aydın Ece; İbrahim Kaplan; Fatma Bozkurt; Fesih Aktar; Sedat Bağlı; Recep Tekin
Journal:  Ital J Pediatr       Date:  2014-11-26       Impact factor: 2.638

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.